As the Australian market demonstrates resilience with a 0.44% gain, defying initial predictions of a downturn, nearly every sector found itself in positive territory, showcasing strong performances from Energy and Real Estate. In such an environment, identifying undervalued stocks becomes crucial for investors seeking opportunities to capitalize on potential discounts within the market.
Name | Current Price | Fair Value (Est) | Discount (Est) |
Data#3 (ASX:DTL) | A$6.33 | A$12.31 | 48.6% |
Cettire (ASX:CTT) | A$1.565 | A$3.02 | 48.1% |
Charter Hall Group (ASX:CHC) | A$14.50 | A$28.66 | 49.4% |
MLG Oz (ASX:MLG) | A$0.58 | A$1.15 | 49.4% |
Telix Pharmaceuticals (ASX:TLX) | A$23.84 | A$46.49 | 48.7% |
Aussie Broadband (ASX:ABB) | A$3.54 | A$6.42 | 44.8% |
Ansell (ASX:ANN) | A$33.76 | A$60.63 | 44.3% |
Ingenia Communities Group (ASX:INA) | A$4.64 | A$9.18 | 49.4% |
Genesis Minerals (ASX:GMD) | A$2.48 | A$4.90 | 49.4% |
Millennium Services Group (ASX:MIL) | A$1.145 | A$2.24 | 48.9% |
Click here to see the full list of 41 stocks from our Undervalued ASX Stocks Based On Cash Flows screener.
Let's take a closer look at a couple of our picks from the screened companies.
Overview: Aussie Broadband Limited offers telecommunications and technology services in Australia, with a market cap of A$1.06 billion.
Operations: The company's revenue is derived from various segments including Business (A$96.97 million), Wholesale (A$159.73 million), Residential (A$585.07 million), Symbio Group (A$69.93 million), and Enterprise and Government (A$88.04 million).
Estimated Discount To Fair Value: 44.8%
Aussie Broadband is trading at A$3.54, significantly below its estimated fair value of A$6.42, suggesting it could be undervalued based on cash flows. The company recently announced a share buyback program to optimize capital and enhance shareholder value, indicating financial flexibility. Despite past shareholder dilution and insider selling, earnings are expected to grow at 23.2% annually—outpacing the Australian market—though revenue growth remains moderate at 8.5% per year.
Overview: PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in the United States, Australia, New Zealand, and internationally with a market cap of A$1.41 billion.
Operations: The company's revenue is primarily derived from the development, manufacturing, and commercialization of the NovoSorb Technology, amounting to A$103.23 million.
Estimated Discount To Fair Value: 31.2%
PolyNovo is currently trading at A$2.05, which is 31.2% below its estimated fair value of A$2.98, highlighting potential undervaluation based on cash flows. The company recently reported record monthly sales of A$10.1 million for November 2024 and a year-to-date revenue increase of 25.4%. Earnings are forecast to grow significantly at 38.3% annually, surpassing the Australian market's growth rate, while revenue growth is projected at 17.6% per year.
Overview: Select Harvests Limited operates in Australia, focusing on the cultivation, processing, packaging, and sale of almonds and related by-products with a market capitalization of A$603.96 million.
Operations: The company's revenue primarily comes from its almond segment, which generated A$337.29 million.
Estimated Discount To Fair Value: 35.6%
Select Harvests is trading at A$4.30, significantly below its estimated fair value of A$6.68, suggesting it may be undervalued based on cash flows. The company reported a return to profitability with sales of A$337.29 million and net income of A$1.5 million for the year ended September 2024. Despite recent shareholder dilution, earnings are projected to grow at 36% annually over the next three years, outpacing the Australian market's growth rate.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include ASX:ABB ASX:PNV and ASX:SHV.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。